1. Home
  2. BCSF vs OPK Comparison

BCSF vs OPK Comparison

Compare BCSF & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCSF
  • OPK
  • Stock Information
  • Founded
  • BCSF 2015
  • OPK 2007
  • Country
  • BCSF United States
  • OPK United States
  • Employees
  • BCSF N/A
  • OPK N/A
  • Industry
  • BCSF Finance/Investors Services
  • OPK Biotechnology: Pharmaceutical Preparations
  • Sector
  • BCSF Finance
  • OPK Health Care
  • Exchange
  • BCSF Nasdaq
  • OPK Nasdaq
  • Market Cap
  • BCSF 983.4M
  • OPK 1.1B
  • IPO Year
  • BCSF 2018
  • OPK 1995
  • Fundamental
  • Price
  • BCSF $13.41
  • OPK $1.55
  • Analyst Decision
  • BCSF Buy
  • OPK Buy
  • Analyst Count
  • BCSF 2
  • OPK 3
  • Target Price
  • BCSF $16.50
  • OPK $2.63
  • AVG Volume (30 Days)
  • BCSF 428.1K
  • OPK 2.5M
  • Earning Date
  • BCSF 11-04-2025
  • OPK 11-06-2025
  • Dividend Yield
  • BCSF 13.14%
  • OPK N/A
  • EPS Growth
  • BCSF N/A
  • OPK N/A
  • EPS
  • BCSF 1.66
  • OPK N/A
  • Revenue
  • BCSF $283,687,000.00
  • OPK $664,029,000.00
  • Revenue This Year
  • BCSF N/A
  • OPK N/A
  • Revenue Next Year
  • BCSF N/A
  • OPK $0.84
  • P/E Ratio
  • BCSF $8.24
  • OPK N/A
  • Revenue Growth
  • BCSF N/A
  • OPK N/A
  • 52 Week Low
  • BCSF $13.20
  • OPK $1.11
  • 52 Week High
  • BCSF $19.21
  • OPK $2.04
  • Technical
  • Relative Strength Index (RSI)
  • BCSF 23.38
  • OPK 62.24
  • Support Level
  • BCSF $13.62
  • OPK $1.53
  • Resistance Level
  • BCSF $14.37
  • OPK $1.60
  • Average True Range (ATR)
  • BCSF 0.31
  • OPK 0.05
  • MACD
  • BCSF -0.08
  • OPK 0.00
  • Stochastic Oscillator
  • BCSF 0.57
  • OPK 78.00

About BCSF Bain Capital Specialty Finance Inc.

Bain Capital Specialty Finance Inc is an externally managed, closed-end, non-diversified management investment company. The company's objective is to provide risk-adjusted returns and current income to investors by investing predominantly in middle-market companies with between $10.0 million and $150.0 million in annual EBITDA. Its portfolio of investments includes First Lien Senior Secured Loan, Preferred Equity, Equity Interest, Warrants, and Second Lien Senior Secured Loan among others.

About OPK OPKO Health Inc.

OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.

Share on Social Networks: